Cargando…
Clinical Correlates and Outcomes of Dual Basiliximab and Antithymocyte Globulin Induction in Kidney Transplant Recipients: A National Study
The unplanned use of dual induction therapy with interleukin-2 receptor-blocking antibodies (IL2rAb) and antithymocyte globulin (ATG) may portend adverse outcomes. METHODS. We used national transplant registry data to study clinical correlates and outcomes of single versus dual induction therapy in...
Autores principales: | Lam, Ngan N., Jeong, Rachel, Quinn, Robert R., Ravani, Pietro, Xiao, Huiling, McAdams-DeMarco, Mara, Axelrod, David A., Schnitzler, Mark A., Snyder, Jon J., Lentine, Krista L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276156/ https://www.ncbi.nlm.nih.gov/pubmed/35836670 http://dx.doi.org/10.1097/TXD.0000000000001190 |
Ejemplares similares
-
Incidence, Risk Factors, and Outcomes of Kidney Transplant Recipients Treated With Both Basiliximab and Antithymocyte Globulin
por: Jeong, Rachel, et al.
Publicado: (2020) -
Effect of Early Steroid Withdrawal on Posttransplant Diabetes Among Kidney Transplant Recipients Differs by Recipient Age
por: Ahn, JiYoon B., et al.
Publicado: (2021) -
The Risk of Postkidney Transplant Outcomes by Induction Choice Differs by Recipient Age
por: Ahn, JiYoon B., et al.
Publicado: (2021) -
Tailored Rabbit Antithymocyte Globulin Induction Dosing for Kidney Transplantation
por: Singh, Namita, et al.
Publicado: (2018) -
Financial Evaluation of Kidney Transplant With Hepatitis C Viremic Donors to Uninfected Recipients
por: Axelrod, David A., et al.
Publicado: (2020)